ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Doubling Of Cancer Research Budget To Take Eight Years Under Obama Plan

May 15, 2009

Funding Opportunities.

April 5, 2002

Sledge: Prepare for Genomic Information “Tsunami”

June 10, 2011

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991